Get started
Achieve Life Sciences, Inc.Achieve Life Sciences, Inc.Achieve Life Sciences, Inc.

Achieve Life Sciences, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ACHV chart


Full chart

ACHV upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪159.23 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.13 USD
Net income (FY)
‪−29.82 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪27.69 M‬
Beta (1Y)
0.61

Employees


Employees (FY)
22
Change (1Y)
+2 +10.00%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.36 M‬ USD

About Achieve Life Sciences, Inc.


Sector
Health Technology
CEO
Richard Alistair Balfour Stewart
Headquarters
Vancouver
Website
achievelifesciences.com
Founded
1991
FIGI
BBG000FB8S62
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

ACHV news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ACHV is 4.63 USD — it has decreased by −7.40% in the past 24 hours. Watch Achieve Life Sciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Achieve Life Sciences, Inc. stocks are traded under the ticker ACHV.
ACHV stock has fallen by −0.43% compared to the previous week, the month change is a −11.64% fall, over the last year Achieve Life Sciences, Inc. has showed a 7.93% increase.
We've gathered analysts' opinions on Achieve Life Sciences, Inc. future price: according to them, ACHV price has a max estimate of 30.00 USD and a min estimate of 10.00 USD. Watch ACHV chart and read a more detailed Achieve Life Sciences, Inc. stock forecast: see what analysts think of Achieve Life Sciences, Inc. and suggest that you do with its stocks.
ACHV reached its all-time high on Oct 8, 1997 with the price of 1,856,435.63 USD, and its all-time low was 2.00 USD and was reached on Nov 9, 2022. View more price dynamics on ACHV chart.
See other stocks reaching their highest and lowest prices.
ACHV stock is 15.74% volatile and has beta coefficient of 0.61. Track Achieve Life Sciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Achieve Life Sciences, Inc. there?
Today Achieve Life Sciences, Inc. has the market capitalization of ‪159.22 M‬, it has increased by 0.85% over the last week.
Yes, you can track Achieve Life Sciences, Inc. financials in yearly and quarterly reports right on TradingView.
Achieve Life Sciences, Inc. is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
ACHV earnings for the last quarter are −0.36 USD per share, whereas the estimation was −0.27 USD resulting in a −32.52% surprise. The estimated earnings for the next quarter are −0.32 USD per share. See more details about Achieve Life Sciences, Inc. earnings.
Achieve Life Sciences, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
ACHV net income for the last quarter is ‪−12.51 M‬ USD, while the quarter before that showed ‪−8.46 M‬ USD of net income which accounts for −47.88% change. Track more Achieve Life Sciences, Inc. financial stats to get the full picture.
No, ACHV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 22.00 employees. See our rating of the largest employees — is Achieve Life Sciences, Inc. on this list?
Like other stocks, ACHV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Achieve Life Sciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Achieve Life Sciences, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Achieve Life Sciences, Inc. stock shows the sell signal. See more of Achieve Life Sciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.